Fed. Circ. Told 10X's IP Loss At Odds With Minerva Ruling
By Andrew Karpan ( July 13, 2021, 3:50 PM EDT) -- 10X Genomics is asking the Federal Circuit to review a panel's decision upholding a ruling that the startup infringed Bio-Rad's patents on microfluidic chips used for genetic sequencing, arguing that it can't stand in light of the U.S. Supreme Court's Minerva v. Hologic ruling that narrowed a doctrine blocking inventors from challenging their own patents....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.